362 related articles for article (PubMed ID: 28028005)
1. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
2. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
[TBL] [Abstract][Full Text] [Related]
3. Alpha2-antiplasmin plays a significant role in acute pulmonary embolism.
Matsuno H; Okada K; Ueshima S; Matsuo O; Kozawa O
J Thromb Haemost; 2003 Aug; 1(8):1734-9. PubMed ID: 12911586
[TBL] [Abstract][Full Text] [Related]
4. Increased urokinase and consumption of α
Longstaff C; Locke M
J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
[TBL] [Abstract][Full Text] [Related]
5. Antibody-directed fibrinolysis. An antibody specific for both fibrin and tissue plasminogen activator.
Bode C; Runge MS; Branscomb EE; Newell JB; Matsueda GR; Haber E
J Biol Chem; 1989 Jan; 264(2):944-8. PubMed ID: 2492021
[TBL] [Abstract][Full Text] [Related]
6. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
Hare TR; Gardell SJ
Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162
[TBL] [Abstract][Full Text] [Related]
7. Reprogrammed streptokinases develop fibrin-targeting and dissolve blood clots with more potency than tissue plasminogen activator.
Sazonova IY; McNamee RA; Houng AK; King SM; Hedstrom L; Reed GL
J Thromb Haemost; 2009 Aug; 7(8):1321-8. PubMed ID: 19566545
[TBL] [Abstract][Full Text] [Related]
8. Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.
Urano T; Suzuki Y; Iwaki T; Sano H; Honkura N; Castellino FJ
Curr Drug Targets; 2019; 20(16):1695-1701. PubMed ID: 31309890
[TBL] [Abstract][Full Text] [Related]
9. Thrombolytic therapy in the eighties.
Verstraete M; Collen D
Blood; 1986 Jun; 67(6):1529-41. PubMed ID: 2423156
[No Abstract] [Full Text] [Related]
10. The fibrinolytic system in man.
Collen D; Lijnen HR
Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482
[TBL] [Abstract][Full Text] [Related]
11. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model].
Kawakami K; Takahashi A; Yoshimoto T
No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism.
Reilly CF; Fujita T; Hutzelmann JE; Mayer EJ; Shebuski RJ
Circulation; 1991 Jul; 84(1):287-92. PubMed ID: 1905594
[TBL] [Abstract][Full Text] [Related]
13. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII.
Rijken DC; Abdul S; Malfliet JJ; Leebeek FW; Uitte de Willige S
J Thromb Haemost; 2016 Jul; 14(7):1453-61. PubMed ID: 27148673
[TBL] [Abstract][Full Text] [Related]
14. Biological control of tissue plasminogen activator-mediated fibrinolysis.
Rånby M; Brändström A
Enzyme; 1988; 40(2-3):130-43. PubMed ID: 3139402
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke.
Papadopoulos SM; Chandler WF; Salamat MS; Topol EJ; Sackellares JC
J Neurosurg; 1987 Sep; 67(3):394-8. PubMed ID: 3112328
[TBL] [Abstract][Full Text] [Related]
16. Endogenous alpha2-antiplasmin does not enhance glomerular fibrin deposition or injury in glomerulonephritis.
Kitching AR; Turner AL; O'Sullivan KM; Dewerchin M; Lijnen HR
J Thromb Haemost; 2003 Sep; 1(9):1992-9. PubMed ID: 12941042
[TBL] [Abstract][Full Text] [Related]
17. Serial thrombolysis-related changes after thrombolytic therapy with TPA in patients with acute myocardial infarction.
Ho CH; Wang SP
Thromb Res; 1990 May; 58(3):331-41. PubMed ID: 1693793
[TBL] [Abstract][Full Text] [Related]
18. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
19. Termination of bleeding by a specific, anticatalytic antibody against plasmin.
Zhao T; Houng A; Reed GL
J Thromb Haemost; 2019 Sep; 17(9):1461-1469. PubMed ID: 31136076
[TBL] [Abstract][Full Text] [Related]
20. Thrombolytic properties of Desmodus rotundus (vampire bat) salivary plasminogen activator in experimental pulmonary embolism in rats.
Witt W; Baldus B; Bringmann P; Cashion L; Donner P; Schleuning WD
Blood; 1992 Mar; 79(5):1213-7. PubMed ID: 1536947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]